3Bartsch P, Mairbaurl H, Maggiorini M. Physiological aspects of high-altitude pulmonary edema [J]. J Appl Physiol, 2005,98 : 1-101.
4Clozel M, Hess P, Rey M, et al. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats [J]. Exp Biol Med, 2006, 231 (6):967-73.
5Duplain H, Sartori C, Lepori M, et al. Exhaled nitric oxide in high-altitude pulmonary edema: role in the regulation of pulmonary vascular tone and evidence for a role against inflammation [J]. Am J Respir Crit Care Med, 2000, 162( 1):221-224.
6Pei Jian-ming, Sun Xin, Guo Hai-tao, et al. U50, 488H Depresses Pulmonary Pressure in Rats Subjected to Chronic Hypoxia [J]. J Cardiovasc Pharmacol,2006, 47:594-598.
7Eldridge MW, Podolsky A, Richardson RS, et al. Pulmonary hemody- namic response to exercise in subjects with prior high-altitude pumonary edema [J]. J Appl Physiol, 1996, 81: 911-921.
8Maggiorini M, Brunner-La Rocca HP, Peth S, et al .Both tadalafll and dexamethasone may reduce the incidence of high-altitude pulmonary edema [J]. Ann Intern Med,2006, 145:497-506.
9Schoene RB, Swenson ER, Pizzo CJ, et al. The lung at high altitude: bronchoalveolar lavage in acute mountain sickness and pulmonary edema [J]. J Appl Physiol, 1988, 64:2605-2613.
10Wilhelm J, Sojkova J, Herget J. Production of hydrogen peroxide by alveolar maerophages from rats exposed to subacute and chronic hypoxia [J]. Physiol Res, 1996,45:1985-1991.
